or
forgot password
  • cancer clinical trials in hooksett, NH

  • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    New Hampshire Oncology-Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Breast Cancer
    Surgery in Treating Patients With Prostate Cancer
    New Hampshire Oncology-Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Prostate Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    New Hampshire Oncology-Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Lymphoma
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Lung Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Breast Cancer
    GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
    GSK Clinical Trials Call Center
    Hooksett, New Hampshire 03106-2505
    Colorectal Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    New Hampshire Oncology-Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Breast Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Breast Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Breast Cancer
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Metastatic Cancer, Prostate Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    New Hampshire Oncology-Hematology PA

    Trial Locations
    New Hampshire Oncology-Hematology PA
    New Hampshire Oncology Hematology Associates
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
    New Hampshire Oncology-Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Lymphoma
    Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Lymphoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    New Hampshire Oncology-Hematology PA

    Trial Locations
    New Hampshire Oncology-Hematology PA
    New Hampshire Oncology Hematology Associates
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Colorectal Cancer
    Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
    GSK Investigational Site
    Hooksett, New Hampshire 03106
    Prophylaxis for HPV Infections and Associated Cervical Neoplasia
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    New Hampshire Oncology-Hematology PA

    Trial Locations
    New Hampshire Oncology-Hematology PA
    New Hampshire Oncology Hematology Associates
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer
    GSK Investigational Site
    Hooksett, New Hampshire 03106
    Neoplasms, Breast
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Breast Cancer
    Study To Assess Long Term Safety Of Pazopanib
    GSK Investigational Site
    Hooksett, New Hampshire 03106
    Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    New Hampshire Oncology-Hematology PA

    Trial Locations
    New Hampshire Oncology-Hematology PA
    New Hampshire Oncology Hematology Associates
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    New Hampshire Oncology-Hematology PA

    Trial Locations
    New Hampshire Oncology-Hematology PA
    New Hampshire Oncology Hematology Associates
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    New Hampshire Oncology Hematology Associates
    Hooksett, New Hampshire 03106
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
    GSK Investigational Site
    Hooksett, New Hampshire 03106
    Lung Cancer, Non-Small Cell
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
    GSK Investigational Site
    Hooksett, New Hampshire 03106
    Neoplasms, Breast, Breast Cancer
    The Active After Cancer Trial (AACT)
    Lakes Regional Healthcare Hematology Oncology
    Hooksett, New Hampshire 03106
    Breast Cancer, Colorectal Cancer
    Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Lymphoma
    Phase II Sunitinib Prog Met AIPC
    NH Oncology-Hematology PA
    Hooksett, New Hampshire 03106
    Metastatic Prostate Cancer
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    New Hampshire Oncology-Hematology PA

    Trial Locations
    New Hampshire Oncology-Hematology PA
    New Hampshire Oncology Hematology Associates
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Breast Cancer, Fatigue, Sleep Disorders
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    NH Oncology-Hematology PA
    Hooksett, New Hampshire 03106
    Androgen-independent Prostate Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    New Hampshire Oncology-Hematology PA

    Trial Locations
    New Hampshire Oncology-Hematology PA
    New Hampshire Oncology Hematology Associates
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    New Hampshire Oncology Hematology Associates
    Hooksett, New Hampshire 03106
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
    GSK Investigational Site
    Hooksett, New Hampshire 03106
    Solid Tumors, Neoplasms, Breast, Cancer
    Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
    Research Site
    Hooksett, New Hampshire
    Breast Cancer, Breast Neoplasms, Breast Tumors, Cancer, Locally Recurrent and Metastatic Breast Cancer, Metastases, Metastatic Cancer, Oncology, Solid Tumors, Tumors
    Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
    Research Site
    Hooksett, New Hampshire
    Non-Small Cell Lung Cancer, Anemia, Cancer, Lung Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    New Hampshire Oncology-Hematology PA

    Trial Locations
    New Hampshire Oncology-Hematology PA
    New Hampshire Oncology Hematology Associates
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Brain and Central Nervous System Tumors
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Brain and Central Nervous System Tumors
    Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
    New Hampshire Oncology - Hematology, PA - Hooksett
    Hooksett, New Hampshire 03106
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms